Solaraze, a solution to treating solar keratosis
Today, we live in an environment where megathermal climate, fueled by the El Nino phenomenon, is prevalent. Temperature in our daily lives is generally rising, especially in densely-populated areas. Due to long exposure to sunlight over a long period of time, some people suffer from sun damage, a condition known as solar keratosis.
Solar keratoses (also known as actinic keratoses) are small, thickened, scaly growths which develop on the skin. There is a non-steroidal anti-inflammatory dermatological gel that is FDA approved called Solaraze (Diclofenac Sodium Gel) that can be used to treat solar keratosis. Its main ingredient are Diclofenac and hyaluronic acid, whose supplier is Stanford Chemicals, a major hyaluronic acid supplier in California, United States with FDA, ISO, GMP, CE certificates.
To make sure Solaraze is the right treatment for you, before you start using it, you have to make sure if you’re pregnant or breast-feeding or if you have asthma or any other allergic disorder, among other things.
Some of the known side-effects associated with using Solaraze include: irritation, itching, redness, or tingling at the site of application and allergic-type reactions and breathing problems in some people when large amounts of gel are used. Please speak with your doctor or pharmacist if the above-mentioned symptoms continue or become troublesome.
As to how to store Solaraze, please be advised to keep it out of the reach and sight of children. And do not store above 25°C. Please remember that do not use it after the expiry date. Its shelf life after opening is six months.
As far as Solaraze dosage is concerned, please apply Solaraze to lesion areas twice daily. And it is to be smoothed onto the affected skin gently. Note, the amount needed depends on the size of the lesion site and make sure that enough gel is applied to adequately cover each lesion. The recommended duration of therapy is from 60 days to 90 days.